BCAX Annual Net Income
-$51.98 M
-$14.14 M-37.36%
01 December 2023
Summary:
As of January 20, 2025, BCAX annual net profit is -$51.98 million, with the most recent change of -$14.14 million (-37.36%) on December 1, 2023. During the last 3 years, it has fallen by -$14.14 million (-37.36%). BCAX annual net income is now -37.36% below its all-time high of -$37.84 million, reached on December 1, 2022.BCAX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCAX Quarterly Net Income
-$17.48 M
0.00%
30 September 2024
Summary:
As of January 20, 2025, BCAX quarterly net profit is -$17.48 millionOver the past year, it has increased by +$5.36 million (+23.48%). BCAX quarterly net income is now at all-time high.BCAX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCAX TTM Net Income
-$17.48 M
0.00%
30 September 2024
Summary:
As of January 20, 2025, BCAX TTM net profit is -$17.48 millionOver the past year, it has increased by +$5.36 million (+23.48%). BCAX TTM net income is now at all-time high.BCAX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCAX Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -37.4% | +23.5% | +23.5% |
| 3 y3 years | -37.4% | +23.5% | +23.5% |
| 5 y5 years | -37.4% | +23.5% | +23.5% |
BCAX Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -37.4% | at low | at high | +23.5% | at high | +23.5% |
| 5 y | 5-year | -37.4% | at low | at high | +23.5% | at high | +23.5% |
| alltime | all time | -37.4% | at low | at high | +23.5% | at high | +23.5% |
Bicara Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$17.48 M(-23.5%) | -$17.48 M(-23.5%) |
| Dec 2023 | -$51.98 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$22.84 M | -$22.84 M |
| Dec 2022 | -$37.84 M | - | - |
FAQ
- What is Bicara Therapeutics annual net profit?
- What is the all time high annual net income for Bicara Therapeutics?
- What is Bicara Therapeutics annual net income year-on-year change?
- What is Bicara Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Bicara Therapeutics?
- What is Bicara Therapeutics quarterly net income year-on-year change?
- What is Bicara Therapeutics TTM net profit?
- What is the all time high TTM net income for Bicara Therapeutics?
- What is Bicara Therapeutics TTM net income year-on-year change?
What is Bicara Therapeutics annual net profit?
The current annual net income of BCAX is -$51.98 M
What is the all time high annual net income for Bicara Therapeutics?
Bicara Therapeutics all-time high annual net profit is -$37.84 M
What is Bicara Therapeutics annual net income year-on-year change?
Over the past year, BCAX annual net profit has changed by -$14.14 M (-37.36%)
What is Bicara Therapeutics quarterly net profit?
The current quarterly net income of BCAX is -$17.48 M
What is the all time high quarterly net income for Bicara Therapeutics?
Bicara Therapeutics all-time high quarterly net profit is -$17.48 M
What is Bicara Therapeutics quarterly net income year-on-year change?
Over the past year, BCAX quarterly net profit has changed by +$5.36 M (+23.48%)
What is Bicara Therapeutics TTM net profit?
The current TTM net income of BCAX is -$17.48 M
What is the all time high TTM net income for Bicara Therapeutics?
Bicara Therapeutics all-time high TTM net profit is -$17.48 M
What is Bicara Therapeutics TTM net income year-on-year change?
Over the past year, BCAX TTM net profit has changed by +$5.36 M (+23.48%)